Home » Stocks » ZY

Zymergen, Inc. (ZY)

Stock Price: $44.05 USD -0.84 (-1.87%)
Updated Jun 17, 2021 1:54 PM EDT - Market open
Market Cap 4.31B
Revenue (ttm) 13.28M
Net Income (ttm) n/a
Shares Out 97.94M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 17
Last Price $44.05
Previous Close $44.89
Change ($) -0.84
Change (%) -1.87%
Day's Open 44.19
Day's Range 44.00 - 45.50
Day's Volume 270,516
52-Week Range 25.75 - 52.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming Goldman Sachs Annual Global Healthcare Virtual Confer...

1 week ago - GlobeNewsWire

SEATTLE--(BUSINESS WIRE)--Accelerator Life Science Partners (“ALSP”), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Co...

2 weeks ago - Business Wire

Tech stocks are on display in Softbank's Vision Fund. These seven are among the best ones, now public, to consider investing in.

Other stocks mentioned: SFTBY, CPNG, DASH, NVDA, TXG, UBER, XM
3 weeks ago - InvestorPlace

Here's a quick look at some earnings reports that were released after markets closed on Monday or before Tuesday's opening bell.

Other stocks mentioned: AZO, RIDE
3 weeks ago - 24/7 Wall Street

EMERYVILLE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world's leading biofacturing companies, today reported preliminary financial results for the first quarter end...

3 weeks ago - GlobeNewsWire

As if to underscore the shrinking number of earnings reports now trickling rather than pouring out of U.S.

Other stocks mentioned: AZO, RIDE
3 weeks ago - 24/7 Wall Street

EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference.

3 weeks ago - GlobeNewsWire

Less than a month ago, Zymergen Inc. (NASDAQ: ZY) came public, raising $500 million in an upsized traditional IPO.

1 month ago - 24/7 Wall Street

EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 202...

1 month ago - GlobeNewsWire

Here's what to look for and what to steer clear of.

Other stocks mentioned: CLXT, TMO
1 month ago - The Motley Fool

The synthetic biology upstart will have enough cash to hit the ground running.

1 month ago - The Motley Fool

EMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world's foremost biofacturing companies, today announced the closing of its initial public offering of 18,54...

1 month ago - GlobeNewsWire

"I love the symbolism that we're going public on Earth Day," says Zymergen's Josh Hoffman. The synthetic biology company raised $500 million in an IPO set to value the company at more than $3 billion.

1 month ago - Forbes

EMERYVILLE, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world's foremost biofacturing companies, today announced the pricing of its initial public offering of 16,13...

1 month ago - GlobeNewsWire

There have been quite a few appealing Initial Public Offerings (IPOs) available on the market so far this year. Here are some upcoming IPOs that investors should be watching out for.

Other stocks mentioned: NPCE, PATH, SKYT, SWIM
1 month ago - Benzinga

This week's offerings don't have quite the same high profile as last week's highly anticipated IPO of Coinbase Global (NASDAQ: COIN). Nevertheless, there are several exciting IPOs that investors should ...

Other stocks mentioned: PATH, DV, AGLY, KNBE, SKYT, SWIM
1 month ago - Benzinga

Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced...

2 months ago - GlobeNewswire

Zymergen Inc, backed by SoftBank Group Corp Inc's Vision Fund, is looking to raise around $100 million through an initial public offering in the United States, according to a regulatory filing on T...

2 months ago - Reuters

Zymergen, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC

About ZY

Zymergen partners with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse... [Read more...]

Industry
Chemicals
IPO Date
Apr 22, 2021
CEO
Joshua Hoffman
Employees
754
Stock Exchange
NASDAQ
Ticker Symbol
ZY
Full Company Profile

Financial Performance

In 2020, Zymergen's revenue was $13.28 million, a decrease of -13.85% compared to the previous year's $15.42 million. Losses were -$262.19 million, 10.7% more than in 2019.

Financial Statements